|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: CGAS |
Gene summary for CGAS |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | CGAS | Gene ID | 115004 |
| Gene name | cyclic GMP-AMP synthase | |
| Gene Alias | C6orf150 | |
| Cytomap | 6q13 | |
| Gene Type | protein-coding | GO ID | GO:0000018 | UniProtAcc | Q8N884 |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 115004 | CGAS | CCI_2 | Human | Cervix | CC | 5.06e-05 | 5.13e-01 | 0.5249 |
| 115004 | CGAS | Tumor | Human | Cervix | CC | 3.83e-04 | -1.08e-01 | 0.1241 |
| 115004 | CGAS | sample1 | Human | Cervix | CC | 1.84e-09 | 5.33e-01 | 0.0959 |
| 115004 | CGAS | T1 | Human | Cervix | CC | 4.12e-18 | 5.26e-01 | 0.0918 |
| 115004 | CGAS | PTC05 | Human | Thyroid | PTC | 7.54e-06 | 3.16e-01 | 0.2065 |
| 115004 | CGAS | ATC09 | Human | Thyroid | ATC | 2.95e-02 | 1.61e-01 | 0.2871 |
| 115004 | CGAS | ATC12 | Human | Thyroid | ATC | 1.15e-03 | 1.29e-01 | 0.34 |
| 115004 | CGAS | ATC13 | Human | Thyroid | ATC | 1.61e-39 | 6.13e-01 | 0.34 |
| 115004 | CGAS | ATC1 | Human | Thyroid | ATC | 4.70e-02 | 1.72e-01 | 0.2878 |
| 115004 | CGAS | ATC2 | Human | Thyroid | ATC | 2.49e-06 | 5.38e-01 | 0.34 |
| 115004 | CGAS | ATC4 | Human | Thyroid | ATC | 1.03e-04 | 1.55e-01 | 0.34 |
| 115004 | CGAS | ATC5 | Human | Thyroid | ATC | 1.15e-38 | 6.77e-01 | 0.34 |
| Page: 1 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Cervix |  | CC: Cervix cancer |
| HSIL_HPV: HPV-infected high-grade squamous intraepithelial lesions | ||
| N_HPV: HPV-infected normal cervix | ||
| Thyroid |  | ATC: Anaplastic thyroid cancer |
| HT: Hashimoto's thyroiditis | ||
| PTC: Papillary thyroid cancer |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| GO:000630212 | Thyroid | ATC | double-strand break repair | 110/6293 | 251/18723 | 4.48e-04 | 2.65e-03 | 110 |
| GO:005160712 | Thyroid | ATC | defense response to virus | 115/6293 | 265/18723 | 5.31e-04 | 3.09e-03 | 115 |
| GO:014054612 | Thyroid | ATC | defense response to symbiont | 115/6293 | 265/18723 | 5.31e-04 | 3.09e-03 | 115 |
| GO:009034211 | Thyroid | ATC | regulation of cell aging | 33/6293 | 61/18723 | 7.76e-04 | 4.28e-03 | 33 |
| GO:007135912 | Thyroid | ATC | cellular response to dsRNA | 15/6293 | 22/18723 | 9.63e-04 | 5.13e-03 | 15 |
| GO:003247913 | Thyroid | ATC | regulation of type I interferon production | 47/6293 | 95/18723 | 9.81e-04 | 5.21e-03 | 47 |
| GO:003260613 | Thyroid | ATC | type I interferon production | 47/6293 | 95/18723 | 9.81e-04 | 5.21e-03 | 47 |
| GO:000181924 | Thyroid | ATC | positive regulation of cytokine production | 189/6293 | 467/18723 | 1.00e-03 | 5.31e-03 | 189 |
| GO:004508813 | Thyroid | ATC | regulation of innate immune response | 94/6293 | 218/18723 | 2.05e-03 | 9.71e-03 | 94 |
| GO:000221812 | Thyroid | ATC | activation of innate immune response | 28/6293 | 52/18723 | 2.08e-03 | 9.82e-03 | 28 |
| GO:2000772 | Thyroid | ATC | regulation of cellular senescence | 28/6293 | 53/18723 | 3.01e-03 | 1.36e-02 | 28 |
| GO:00510531 | Thyroid | ATC | negative regulation of DNA metabolic process | 57/6293 | 125/18723 | 3.47e-03 | 1.55e-02 | 57 |
| GO:00713601 | Thyroid | ATC | cellular response to exogenous dsRNA | 12/6293 | 18/18723 | 4.22e-03 | 1.79e-02 | 12 |
| GO:004333111 | Thyroid | ATC | response to dsRNA | 27/6293 | 55/18723 | 1.24e-02 | 4.38e-02 | 27 |
| GO:0045738 | Thyroid | ATC | negative regulation of DNA repair | 19/6293 | 36/18723 | 1.37e-02 | 4.77e-02 | 19 |
| Page: 1 2 3 4 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| hsa0517120 | Cervix | CC | Coronavirus disease - COVID-19 | 111/1267 | 232/8465 | 1.82e-33 | 5.90e-31 | 3.49e-31 | 111 |
| hsa0516318 | Cervix | CC | Human cytomegalovirus infection | 65/1267 | 225/8465 | 4.59e-08 | 6.47e-07 | 3.83e-07 | 65 |
| hsa0513120 | Cervix | CC | Shigellosis | 69/1267 | 247/8465 | 7.64e-08 | 1.03e-06 | 6.10e-07 | 69 |
| hsa0517016 | Cervix | CC | Human immunodeficiency virus 1 infection | 55/1267 | 212/8465 | 1.80e-05 | 1.42e-04 | 8.40e-05 | 55 |
| hsa05171110 | Cervix | CC | Coronavirus disease - COVID-19 | 111/1267 | 232/8465 | 1.82e-33 | 5.90e-31 | 3.49e-31 | 111 |
| hsa0516319 | Cervix | CC | Human cytomegalovirus infection | 65/1267 | 225/8465 | 4.59e-08 | 6.47e-07 | 3.83e-07 | 65 |
| hsa05131110 | Cervix | CC | Shigellosis | 69/1267 | 247/8465 | 7.64e-08 | 1.03e-06 | 6.10e-07 | 69 |
| hsa0517017 | Cervix | CC | Human immunodeficiency virus 1 infection | 55/1267 | 212/8465 | 1.80e-05 | 1.42e-04 | 8.40e-05 | 55 |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| Page: 1 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |